Skip to main content
Indegene Limited logo

Indegene Limited — Investor Relations & Filings

Ticker · INDGN ISIN · INE065X01017 LEI · 335800XFEREFIW9LG995 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 292 across all filing types
Latest filing 2024-08-08 Audit Report / Informat…
Country IN India
Listing BSE.NS INDGN

About Indegene Limited

https://www.indegene.com/

Indegene Limited provides digital-led commercialization services for the life sciences sector. The company integrates deep domain knowledge with proprietary technology platforms to assist biopharmaceutical, emerging biotech, and medical device organizations. Its core offerings span the entire product lifecycle, including clinical development support, regulatory compliance, pharmacovigilance, and multi-channel marketing operations. By leveraging artificial intelligence and machine learning, Indegene enables clients to optimize drug development processes, enhance patient engagement, and drive operational efficiencies. The company focuses on modernizing traditional commercial models through data-driven insights and digital transformation strategies, helping global healthcare organizations navigate complex regulatory environments and improve health outcomes through scaled, technology-enabled solutions.

Recent filings

Filing Released Lang Actions
Statement of deviation(s) or variation(s) under Reg. 32
Audit Report / Information Classification · 95% confidence The document is titled 'Monitoring Agency Report for the quarter ended June 30, 2024' and is issued pursuant to SEBI regulations related to IPO proceeds monitoring. It contains detailed information on the utilization of IPO proceeds, including issuer details, issue details, deployment of funds, and compliance with regulatory requirements. The report is prepared by a monitoring agency (CARE Ratings Limited) appointed to monitor the utilization of IPO proceeds. The document is substantive, about 15,000 characters long, and contains detailed financial and compliance data related to the IPO proceeds utilization for a quarter. This fits the definition of a specialized report related to monitoring and audit of IPO proceeds utilization, which is distinct from a full Annual Report or Interim Report. It is not a simple announcement or certification but a detailed monitoring report. Given the nature of the document and the regulatory context, the most appropriate classification is Audit Report / Information (AR), as it is a standalone audit/monitoring report related to regulatory compliance and financial monitoring of IPO proceeds, not a full annual or quarterly financial report.
2024-08-08 English
Updates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges and shareholders, dated August 6, 2024. It reports on decisions made by the Board of Directors at a meeting held on August 1, 2024. The content includes approval of amendments to insider trading policies, nomination rights subject to shareholder approval, approval of the directors report and secretarial auditor's report, and details about the upcoming 26th Annual General Meeting (AGM) including dates for record and book closure. It also mentions the appointment of a scrutinizer for the AGM. The document does not contain the actual directors report or financial statements but rather informs about approvals and upcoming AGM logistics. The length is 3927 characters, which is relatively short and consistent with an announcement rather than a full report. The document is primarily an announcement of board decisions and AGM details, not the AGM materials themselves or the full directors report. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and board information update, rather than AGM Information (AGM-R) or Annual Report (10-K).
2024-08-06 English
Copy of Newspaper Publication
Earnings Release Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) dated August 5, 2024, regarding the publication of financial results for the quarter ended June 30, 2024. It mentions the newspaper advertisement of the financial results and states that the advertisement is enclosed and also posted on the company's website. The document is about the announcement of the financial results publication, not the full financial report itself. The length is about 15,000 characters, but the content is primarily an announcement and includes newspaper advertisement text rather than detailed financial statements or management discussion. Therefore, this document fits the category of Earnings Release (ER) as it is the initial announcement of quarterly financial results highlights, typically published in newspapers and stock exchange filings under SEBI regulations.
2024-08-05 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the audio recording of the Q1FY25 earnings call. It references the SEBI regulations for disclosure and provides a link to the audio recording of the earnings call. The document does not contain the transcript or detailed financial data but is an announcement about the availability of the earnings call recording. The document length is short (1460 characters), and it serves as a notification rather than the full transcript or financial report. Therefore, it fits best under the category of Call Transcript (CT) as it relates directly to the earnings call content, but since it only provides the audio link and not the transcript, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is an announcement of the availability of the earnings call recording rather than the transcript itself or a financial report. However, given the options and the nature of the document, the best fit is Regulatory Filings (RNS).
2024-08-02 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges informing about the opening of the trading window for insiders to trade company securities. It references compliance with SEBI (Prohibition of Insider Trading) Regulations and the company's internal code of conduct. The purpose is to notify the market and regulatory bodies about the trading window opening in connection with the upcoming financial results announcement. The document is short (1705 characters) and does not contain any financial data, report content, or detailed analysis. It is an announcement related to insider trading compliance rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2024-08-02 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges about the schedule of meetings with investors and analysts. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30(6), which pertains to disclosure of material events or information. The content is about informing the exchanges and public about upcoming investor/analyst meetings and does not contain any financial data, report, or detailed presentation. It is an announcement of an event rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-08-02 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.